Comorbidities in heart failure with preserved ejection fraction

Area of Science:

• Cardiology
• Geriatrics
• Public Health

Background:

• Chronic heart failure (CHF) is a leading cause of hospitalization and mortality in industrialized nations.
• Aging populations are increasing CHF prevalence and associated comorbidities, worsening patient prognosis.
• Heart failure with preserved ejection fraction (HFpEF) presents a complex clinical challenge with limited evidence-based treatment options.

Purpose of the Study:

• To review major comorbidities in CHF, including their prevalence, prognostic impact, and current treatment strategies.
• To discuss the challenges in managing HFpEF and the current status of its treatment.
• To emphasize the importance of optimized care and prevention in managing CHF.

Main Methods:

• Literature review of major comorbidities associated with chronic heart failure.
• Analysis of prevalence, impact on prognosis, and treatment approaches for selected comorbidities.
• Discussion of current study status and challenges in HFpEF management.

Main Results:

• Key comorbidities include atrial fibrillation, arterial hypertension, coronary artery disease, renal dysfunction, and type 2 diabetes.
• These comorbidities significantly impact CHF prognosis and survival.
• Current HFpEF treatment relies on managing comorbidities, with no specific HFpEF therapies recommended.

Conclusions:

• Optimized care structures integrating inpatient and outpatient services are crucial for reducing hospitalizations.
• Focus remains on symptom relief and managing associated comorbidities.
• Prevention through early risk factor minimization is the most effective current strategy for CHF.